Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
23 Nov 2022
Research update Midsummer, Q3 2022: New support for major initiative
Equity Research
Midsummer
07 Jun 2022
Research update Midsummer, Q1 2022: Project Invitalia takes valuable steps forward
Equity Research
Midsummer
18 Mai 2022
First impression Midsummer, Q1 2022: Adjusted result in line with expectations. The Invitalia project continues
Equity Research
Midsummer
08 Mrz 2022
Research Update Midsummer, Q4 2021: Strong quarter with good growth prospects
Equity Research
Midsummer
25 Feb 2022
First impression, Midsummer q4 2021: Strong momentum in both business areas
Equity Research
Midsummer
16 Dez 2021
Mrkt BUZZ Midsummer: Breakthrough order strengthens momentum
Equity Research
Midsummer
24 Nov 2021
Mrkt BUZZ Midsummer: Key people subscribe - a good signal value
Equity Research
Midsummer